US Patent Issued to HK TUMESCENT PHARMA on May 20 for "Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,591, issued on May 20, was assigned to HK TUMESCENT PHARMA (San Clemente, Calif.).

"Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity" was invented by Jeffrey Alan Klein (San Juan Capistrano, Calif.) and Paytra Alan Klein (Newport Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tumescent composition comprising a biologic drug in a tumescent solution, wherein a tumescent concentration of the biologic drug is simultaneously below a threshold for local, subcutaneous tissue toxicity, above a threshold for positive local therapeutic...